Abstract
This study was conducted on 40 biopsy proved patients of head and neck cancers,85% of patients presented with squamous cell carcinoma in various grades of differentiation. When seruma denosine deaminase activity was compared between controls and cases, significant increase was found in the activities (control 51.54 ±12.09 IU/L and cases 106.87 ±29.75 IU/ L). The duration of illness didn’t reflect any statistical significance with the adenosine deminase activity. It was 97.59 ±62.93 IU/L in case where duration of illness was 98 ±30.98 IU/L in patient with more than one year of disease. The lymph node showed stronger correlation with adenosine deaminase activity, its level was 83.41±1.41 IU/L in patients with N3 The rise in serum adenosine deaminase activity was found to be directly related to the stage I disease. It was 57.80 ±4.60 IU/ L in patient with stage I disease while in patients with stage IV had 135.87 ±18.39 IU/L of activity. According to histological grading, highest level was found in patients having squamous cell carcinoma( 113.41 ±32 IU/L). The activity of adenosine deaminase decreases with radiotherapy and after surgery. This may help in assessing the decrease in tumour mass and improvement in patient’s clinical condition.
Key Words: Serum Adenosine Deaminase, Head and Neck Malignancy
Full Text
The Full Text of this article is available as a PDF (509.3 KB).
References
- 1.Bagantha M.R, Pego A., Limba M.A., Gasper E.V., Cardeiro A.R. Serum and pleural adenosine deaminase correlation with lymphocytic populations. Chest. 1990;9713:605–10. doi: 10.1378/chest.97.3.605. [DOI] [PubMed] [Google Scholar]
- 2.Brozenko B.G. Use of the study of DNA metabolism enzyme activities as a test system in the treatment of breast cancer. Sovnnied. 1991;2:14–7. [PubMed] [Google Scholar]
- 3.Giusti G. Adenosine deaminase. Meth. Enz. Anal. 1974;2:1092–9. [Google Scholar]
- 4.Hall J.G. (1963) : Adenosine deaminase activity in lymphoid cells during antibody production. Aust. J. Exp. Biol. Med. Sci. 41–93. [DOI] [PubMed]
- 5.Ishii A., Green H. Lethality of adenosine for cultured mammalian cells by interference with pyrimidine biosynthesis. Journal of cells science. 1973;13:419–439. doi: 10.1242/jcs.13.2.429. [DOI] [PubMed] [Google Scholar]
- 6.Koehler L.H, Benz E. J. Serum adenosine deaminase: Methodolgy and Clinical applications. Clinical Chemistry. 1962;8:133–140. [PubMed] [Google Scholar]
- 7.Madeda K., Monta K., Shibata T., Naito Y., Mizuno A. Simultaneous assay of adenosine deaminase and purine. Nucleoside Phosphorylase activity as possible biochemical mean to detect non-hodgkin lymphomas of the oral cavity. cancer. 1992;70((1)):20–27. doi: 10.1002/1097-0142(19920701)70:1<20::AID-CNCR2820700104>3.0.CO;2-#. [DOI] [PubMed] [Google Scholar]
- 8.Malan C, Donald P. R., Golden M., TAlaard J.J.F. Adenosine deaminase level in cerebro-spinal fluid in the diagnosis of tuberculous meningitis. J. Trop. Med. Hyg. 1984;87:33–40. [PubMed] [Google Scholar]
- 9.Ocana I., Martinez-Vazquez J. M., Ribera E., Segura R. M, Pascal C. Adenosine deaminase activity in the diagnosis of lymphocytic pleural effusion of tuberculosis neoplastic and lymphomatous origin. Tubercle. 1986;67:141–145. doi: 10.1016/0041-3879(86)90008-5. [DOI] [PubMed] [Google Scholar]
- 10.Ribera E., Martinnez -Vazquez I., Ocana I., Segura R. M, Pascal C. Activity of adenosine deaminase in cerebrospinal fluid for the diagnosand follow up of tuberculous meningitis in adults. J. infect. Dis. 1987;155:603–607. doi: 10.1093/infdis/155.4.603. [DOI] [PubMed] [Google Scholar]
- 11.Raczynska J., Jonas S., Krawergnsted J. diagnostic Value of adenosine deaminase in some liver diseases. Clinica Chimica Acta. 1966;13:151–154. doi: 10.1016/0009-8981(66)90288-9. [DOI] [PubMed] [Google Scholar]
- 12.Segura R. M., Pascual C., Ocana I. : Martinex-Vazquez J.M, Ribera E., Ruiz I., Pelegri M.D. Adenosine deaminase in body fluids : a useful diagnosis tool in tuberculosis. Clin. Biochem. 1986;22:141–148. doi: 10.1016/S0009-9120(89)80013-X. [DOI] [PubMed] [Google Scholar]
- 13.Sufrin G., Tritsch G. L., Mittelman A., Murphy G.P. Adenosine deaminase activity in patients with carcinoma of the bladder. J. Urology. 1978;119:343–346. doi: 10.1016/s0022-5347(17)57486-8. [DOI] [PubMed] [Google Scholar]
- 14.Tung R., silber R., Ogliate F., Conklyn M., Gottesman J., Hirschorn R. ADA activity in CLL. Relationship to B and T Cell subpopulation. J. Clin Tnves. 1976;57:576–576. doi: 10.1172/JCI108313. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Uberti J., Johnson R. M., Talley R., Lightbody J. J. decreased lymphocyte adenosine deaminase activity in tumor patients. Cancer Res. 1976;36:2046–2046. [PubMed] [Google Scholar]
- 16.Zimmer J., Khalifa A. S., Lightbody J. J. Decreased lymphocyte adenosine deaminase activity in acute lymphocytic leudemic children and their parents. Cancer Res. 1975;35:68–70. [PubMed] [Google Scholar]